Prominence Advisors Acquires Tegra Analytics, Marking Entry into Life Sciences

The Partnership Brings Together Healthcare and Life Sciences Expertise to Drive Data Enablement Innovation

CHICAGO, Sept. 3, 2025 /PRNewswire/ -- Prominence Advisors, the nation's leader in healthcare data enablement, announced the acquisition of Tegra Analytics, a life sciences analytics consultancy. The partnership extends Prominence's proven data enablement platform into life sciences, strengthening its service across providers, payers, and life sciences organizations.

Founded in 2002, Tegra Analytics brings deep statistical expertise and extensive domain experience across the commercial and clinical lifecycles of pharmaceutical, biotech, and medical device organizations. Known for delivering highly customized analytical solutions – including innovative sales operations initiatives, robust data platforms, actionable dashboards, and advanced analytical support – Tegra helps life sciences companies operationalize data to drive performance and innovation.

By joining forces, Prominence gains immediate access to a robust portfolio of advanced analytics capabilities in the life sciences space, enhancing its ability to serve pharmaceutical, biotech, and commercial organizations through end-to-end data strategy.

"With Tegra Analytics, we're expanding the reach of our data platform to unify healthcare and life sciences data – helping organizations accelerate discoveries, improve patient outcomes, and reduce costs," said Bobby Bacci, CEO of Prominence Advisors.

"By combining our strategic consulting expertise with Prominence's robust data assets and technology infrastructure, we're uniquely positioned to help life sciences companies make faster, smarter, and more impactful decisions. We're thrilled about the expanded opportunities this creates for our clients and our team," said Matt Hutcheson, CEO of Tegra Analytics.

Together, Prominence and Tegra will support data modernization and infrastructure development across the healthcare sector and deliver actionable insights through AI-driven analytics.

About Prominence Advisors
Prominence Advisors, headquartered in Chicago, is the Healthcare Data Enablement company, helping healthcare organizations harness the power of their data to improve patient outcomes, reduce the cost of care, and increase operational efficiency. Uniquely positioned at the intersection of EMR expertise, data and analytics, and intelligent automation, Prominence partners with leading health systems nationwide to solve their most complex challenges. The firm is highly rated by KLAS in four categories, winning two Best in KLAS awards for HIT Staffing and Technical Services, reflecting its commitment to excellence and measurable results. Through deep partnerships with leading technology providers – including AWS, Microsoft, Databricks, Snowflake, Tableau, Salesforce, Informatica, and Collibra – Prominence enables organizations to modernize in the cloud, harmonize data post-merger, ensure revenue integrity, and accelerate adoption of AI-driven automation. By embedding insights directly into workflows, designing modern data architectures, and orchestrating intelligent processes, Prominence empowers healthcare organizations to turn insights into innovation and achieve meaningful ROI. For more information, please visit: www.prominenceadvisors.com

About Tegra Analytics
Tegra Analytics, with offices in Columbia, SC, Philadelphia, and Cincinnati, is a boutique consulting firm dedicated exclusively to analytics and commercial operations support for the life sciences industry. For more than 23 years, Tegra has partnered with leading pharmaceutical, biopharma, and medical device companies – including seven of the top ten global pharma firms – delivering customized solutions that support territory alignments, call planning, targeting and segmentation, incentive compensation, forecasting, and reporting. With a team of U.S.-based statisticians, programmers, analysts, and consultants, Tegra has delivered hundreds of successful projects spanning forecasting, segmentation, alignment, and incentive compensation, helping life sciences organizations optimize their commercial strategies and performance. The company is recognized for its expertise across dozens of therapeutic areas including oncology, neurology, rare disease, women's health, cardiology, and more. Guided by its values of involvement, customization, expertise, flexibility, and trust, Tegra serves as a long-term, trusted extension of client teams, combining technical excellence with tailored solutions to improve outcomes. For more information, please visit: www.tegraanalytics.com.

SOURCE Prominence Advisors